Dr. Jerome Howell, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Blvd, Cookeville, TN 38501 Phone: 931-783-2770 Fax: 931-525-1176 |
Dr. Mark Allen Clapp, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 N Washington Ave, Suite 130, Cookeville, TN 38501 Phone: 931-526-1050 Fax: 931-526-8163 |
Dr. John W Minchey, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 142 W 5th St, Cookeville, TN 38501 Phone: 866-313-5259 Fax: 205-313-5298 |
Charles T Huddleston, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 N Cedar Ave, Cookeville, TN 38501 Phone: 931-528-1992 Fax: 931-526-4381 |
Robert E Paasche, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Blvd, Cookeville, TN 38501 Phone: 931-783-2334 Fax: 931-783-2253 |
Dr. Louis Charles Frazier, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Blvd, Cookeville, TN 38501 Phone: 931-783-2334 |
News Archive
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
A group of oncologists have revealed in a new study by Ben-Gurion University of the Negev (BGU) researchers that communicating about death and dying with their patients is one of the most difficult and stressful parts of their work.
EcoNugenics® is proud to introduce BreastDefend™, a new nutraceutical compound formulated specifically to promote and maintain breast health. Physician-formulated BreastDefend is crafted from eight exclusive, clinically tested compounds, including scientifically supported nutrients, herbs, and medicinal mushrooms.
GenoMed, Inc. has announced that the country's second case of West Nile virus encephalitis has responded promptly to its treatment approach. So far, GenoMed's treatment is showing a 100% response rate among 13 immunocompetent patients. The sooner the treatment is instituted, the more rapid and more complete the response.
› Verified 2 days ago